HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Thomas Silfverberg Selected Research
Thomas Silfverberg Research Topics
Disease
2
Relapsing-Remitting Multiple Sclerosis
09/2023 - 01/2021
1
Hematologic Neoplasms (Hematological Malignancy)
01/2022
1
COVID-19
01/2022
1
Inborn Urea Cycle Disorders
09/2018
1
Brain Edema (Cerebral Edema)
09/2018
1
Gastrointestinal Hemorrhage (Hematochezia)
09/2018
1
Hyperammonemia
09/2018
1
Leukocytosis (Pleocytosis)
03/2012
1
Thrombocytopenia (Thrombopenia)
03/2012
Drug/Important Bio-Agent (IBA)
1
Alemtuzumab (Campath)
FDA Link
01/2021
1
Proteins (Proteins, Gene)
FDA Link
09/2018
1
HHH syndrome
IBA
09/2018
Therapy/Procedure
2
Stem Cell Transplantation
09/2023 - 01/2021
1
Hematopoietic Stem Cell Transplantation
01/2022
1
Aftercare (After-Treatment)
01/2021
1
Continuous Renal Replacement Therapy
09/2018
1
Therapeutics
03/2012